|
KIF18B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.92799999970883E-07 |
| Normal-vs-Stage2 |
3.121900E-02 |
| Normal-vs-Stage3 |
3.5188999999991E-05 |
| Normal-vs-Stage4 |
8.281300E-03 |
| Stage1-vs-Stage2 |
4.401400E-01 |
| Stage1-vs-Stage3 |
1.218760E-03 |
| Stage1-vs-Stage4 |
3.933900E-02 |
| Stage2-vs-Stage3 |
3.825900E-02 |
| Stage2-vs-Stage4 |
8.575500E-02 |
| Stage3-vs-Stage4 |
9.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.13995487996499E-12 |
| Normal-vs-AfricanAmerican |
3.30039999996146E-06 |
| Normal-vs-Asian |
7.533700E-02 |
| Caucasian-vs-AfricanAmerican |
1.534410E-01 |
| Caucasian-vs-Asian |
1.697430E-01 |
| AfricanAmerican-vs-Asian |
2.089800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6743273434372E-12 |
| Normal-vs-Female |
1.64999999996418E-06 |
| Male-vs-Female |
3.820200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.54219999999917E-05 |
| Normal-vs-Extreme_Weight |
2.47689999954837E-07 |
| Normal-vs-Obese |
4.78049999996788E-06 |
| Normal-vs-Extreme_Obese |
1.818870E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.261400E-01 |
| Normal_Weight-vs-Obese |
8.171200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.997300E-03 |
| Extreme_Weight-vs-Obese |
1.274210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.267910E-02 |
| Obese-vs-Extreme_Obese |
1.797780E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.199800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.42279538045887E-11 |
| Normal-vs-Age(61-80Yrs) |
1.13509999999373E-06 |
| Normal-vs-Age(81-100Yrs) |
1.297660E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.764000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.419960E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.937700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.216200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.347800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.017000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.73510120002629E-11 |
| Normal-VS-Type2 PRCC |
9.45699999976846E-07 |
| Normal-VS-KIRP CIMP |
8.606000E-04 |
| Normal-VS-Unclassified PRCC |
5.423300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.646100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.243800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.488220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.438000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.522400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.463400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80579999999875E-05 |
| Normal-vs-N1 |
1.87614999999086E-05 |
| Normal-vs-N2 |
1.003810E-01 |
| N0-vs-N1 |
1.117650E-03 |
| N0-vs-N2 |
1.940960E-01 |
| N1-vs-N2 |
9.657000E-01 |
|
|
